Science Explorer Back to mapMap
Discussion
Researcher · Addgene · United States

Nikita Kotlov

Nikita Kotlov publishes mostly in Oncology, Pathology and Forensic Medicine and Molecular Biology, on topics such as Lymphoma Diagnosis and Treatment, Cancer Genomics and Diagnostics and CAR-T cell therapy research.

ORCID 0000-0002-6393-7357 OpenAlex
World rank
#609,931
of 7,710,434 ranked researchers
Rank in United States
#208,912
of 1,627,098
Works
215
Citations
3.9k
Citations per work
18.3
h-index
19
i10-index 28Top 25% in Oncology
Nikita Kotlov

What does Nikita Kotlov research?

Nikita Kotlov's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (27%), Immunology and Microbiology (6%).

Health Sciences: 102 works · 47.3% of their workMedicine: 102 works · 47.3% of their workOncology: 43 works · 19.9% of their workPathology and Forensic Medicine: 36 works · 16.6% of their workPulmonary and Respiratory Medicine: 23 works · 10.8% of their workLife Sciences: 71 works · 32.9% of their workBiochemistry, Genetics and Molecular Biology: 58 works · 27.1% of their workMolecular Biology: 33 works · 15.2% of their workCancer Research: 26 works · 11.9% of their workImmunology and Microbiology: 12 works · 5.8% of their workImmunology: 12 works · 5.8% of their workEverything else: 43 works · 19.8% of their workTHEIR WORKNikita Kotlov215works
Life Sciences33%Health Sciences47%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine10247.3%
    1. Biochemistry, Genetics and Molecular Biology5827.1%
    2. Immunology and Microbiology125.8%
  3. Everything else4319.8%
  1. 1Oncology20% of their works
  2. 2Pathology and Forensic Medicine17% of their works
  3. 3Molecular Biology15% of their works
  4. 4Cancer Research12% of their works
  5. 5Pulmonary and Respiratory Medicine11% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Nikita Kotlov's research?

The keywords of their largest research topics: Lymphoma, Rituximab, Classification, Molecular Profiling, Tumor Microenvironment, Cancer Genomics, Mutational Signatures and Prognostic Factors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Lymphoma742 topics
  2. Rituximab702 topics
  3. Classification521 topic
  4. Molecular Profiling521 topic
  5. Tumor Microenvironment342 topics
  6. Cancer Genomics281 topic
  7. Mutational Signatures281 topic
  8. Prognostic Factors272 topics
  9. CAR T Cells221 topic
  10. Chimeric Antigen Receptor221 topic
  11. Immune Checkpoint Blockade201 topic
  12. PD-1 and PD-L1201 topic
  13. Chronic Lymphocytic Leukemia181 topic
  14. Genomic Aberrations181 topic
  15. Cancer141 topic
  16. Ferroptosis141 topic
  17. Epstein-Barr Virus111 topic
  18. Kaposi's Sarcoma111 topic
  19. Osteosarcoma91 topic
  20. Soft Tissue Sarcoma91 topic

Where does Nikita Kotlov work?

Nikita Kotlov's main affiliation in the publication record is Addgene, United States.

How many publications and citations does Nikita Kotlov have?

OpenAlex counts 215 works and 3,930 citations for Nikita Kotlov, an h-index of 19, ranking #609,931 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nikita Kotlov. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.